These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27049853)

  • 1. Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration.
    Morden E; Technau KG; Giddy J; Maxwell N; Keiser O; Davies MA
    PLoS One; 2016; 11(4):e0151762. PubMed ID: 27049853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
    Venkatesh KK; Lurie MN; Triche EW; De Bruyn G; Harwell JI; McGarvey ST; Gray GE
    Trop Med Int Health; 2010 Nov; 15(11):1364-74. PubMed ID: 20955499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
    Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Zerbe A; le Roux DM; Kroon M; Myer L
    Lancet Child Adolesc Health; 2020 Mar; 4(3):220-231. PubMed ID: 31932246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breastfeeding by HIV-1-infected women and outcome in their infants: a cohort study from Durban, South Africa.
    Bobat R; Moodley D; Coutsoudis A; Coovadia H
    AIDS; 1997 Nov; 11(13):1627-33. PubMed ID: 9365768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa.
    Nyemba DC; Kalk E; Madlala HP; Malaba TR; Slogrove AL; Davies MA; Boulle A; Myer L; Powis KM
    BMC Pregnancy Childbirth; 2021 May; 21(1):354. PubMed ID: 33947351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.
    Hofer CB; Keiser O; Zwahlen M; Lustosa CS; Frota AC; de Oliveira RH; Abreu TF; Carvalho AW; Araujo LE; Egger M
    Pediatr Infect Dis J; 2016 Jan; 35(1):71-7. PubMed ID: 26741583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants.
    Slogrove AL; Esser MM; Cotton MF; Speert DP; Kollmann TR; Singer J; Bettinger JA
    Pediatr Infect Dis J; 2017 Feb; 36(2):e38-e44. PubMed ID: 28081048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan Africa.
    le Roux SM; Abrams EJ; Nguyen K; Myer L
    Trop Med Int Health; 2016 Jul; 21(7):829-45. PubMed ID: 27125333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV infection, viral load, low birth weight, and nevirapine are independent influences on growth velocity in HIV-exposed South African infants.
    Ramokolo V; Lombard C; Fadnes LT; Doherty T; Jackson DJ; Goga AE; Chhagan M; Van den Broeck J
    J Nutr; 2014 Jan; 144(1):42-8. PubMed ID: 24198309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol.
    Coutsoudis A; Daniels B; Moodley-Govender E; Ngomane N; Zako L; Spooner E; Kiepiela P; Reddy S; Kuhn L; Ramjee G
    BMJ Open; 2016 Jul; 6(7):e010656. PubMed ID: 27406638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study.
    Coovadia HM; Rollins NC; Bland RM; Little K; Coutsoudis A; Bennish ML; Newell ML
    Lancet; 2007 Mar; 369(9567):1107-16. PubMed ID: 17398310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
    Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-exposed uninfected infant morbidity and mortality within a nationally representative prospective cohort of mother-infant pairs in Zimbabwe.
    Patel MR; Mushavi A; Balachandra S; Shambira G; Nyakura J; Mugurungi O; Kilmarx PH; Rivadeneira E; Dinh TH
    AIDS; 2020 Jul; 34(9):1339-1346. PubMed ID: 32590432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with non-attendance at scheduled infant follow-up visits in an observational cohort of HIV-exposed infants in South Africa, 2012-2014.
    Ngandu NK; Jackson D; Lombard C; Nsibande DF; Dinh TH; Magasana V; Mogashoa M; Goga AE
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):788. PubMed ID: 31526372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.